Indication
Acute monocytic leukemia
Acute monocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of immature myeloid precursors predominantly committed to the monocytic lineage, primarily affecting the bone marrow and peripheral blood. Read more about Acute monocytic leukemia
44 drugs 39 manufacturers
Drugs that treat it
Common Acute monocytic leukemia therapies.
DAUNORUBICIN HCL
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
DAUNORUBICIN HCL
CYCLOPHOSPHAMIDE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute monocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of immature myeloid precursors predominantly committed to the monocytic lineage, primarily affecting the bone marrow and peripheral blood.
Histologically, it is defined by a high proportion of monoblasts and promonocytes, historically classified under the French-American-British system as AML-M5.
Pathophysiologically, the replacement of normal hematopoietic tissue results in cytopenias leading to anemia, infection, and hemorrhage.
Clinically, it frequently presents with marked hyperleukocytosis and has a pronounced propensity for extramedullary tissue infiltration, classically manifesting as gingival hyperplasia, leukemia cutis, central nervous system involvement, and associated coagulopathies such as disseminated intravascular coagulation.
- nih.gov
Acute monocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of immature myeloid precursors predominantly committed to the monocytic lineage, primarily affecting the bone marrow and peripheral blood Histologically, it is defined by a high proportion of monoblasts and promonocytes, historically classified under the French-American-British system as AML-M5
- medicalnewstoday.com
Acute monocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of immature myeloid precursors predominantly committed to the monocytic lineage, primarily affecting the bone marrow and peripheral blood Histologically, it is defined by a high proportion of monoblasts and promonocytes, historically classified under the French-American-British system as AML-M5 Pathophysiologically, the replacement of normal hematopoietic tissue results in cy...
- clevelandclinic.org
Acute monocytic leukemia is an aggressive subtype of acute myeloid leukemia characterized by the neoplastic proliferation of immature myeloid precursors predominantly committed to the monocytic lineage, primarily affecting the bone marrow and peripheral blood
- nih.gov
Histologically, it is defined by a high proportion of monoblasts and promonocytes, historically classified under the French-American-British system as AML-M5
- nih.gov
Pathophysiologically, the replacement of normal hematopoietic tissue results in cytopenias leading to anemia, infection, and hemorrhage
- cancer.gov
Clinically, it frequently presents with marked hyperleukocytosis and has a pronounced propensity for extramedullary tissue infiltration, classically manifesting as gingival hyperplasia, leukemia cutis, central nervous system involvement, and associated coagulopathies such as disseminated intravascular coagulation
- rarediseases.org
Clinically, it frequently presents with marked hyperleukocytosis and has a pronounced propensity for extramedullary tissue infiltration, classically manifesting as gingival hyperplasia, leukemia cutis, central nervous system involvement, and associated coagulopathies such as disseminated intravascular coagulation
Personalize your experience
Follow Acute monocytic leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.